Literature DB >> 3003020

Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise.

P Hespel, P Lijnen, L Vanhees, R Fagard, A Amery.   

Abstract

The relative role of beta 1- and beta 2-adrenoceptors in the regulation of blood pressure and plasma renin at rest and during exercise was studied in 17 normal male volunteers. They performed, in a randomized order and according to a double-blind crossover study design, three graded and uninterrupted exercise tests until exhaustion after being pretreated during 3 consecutive days with a placebo, with a predominantly beta 1-blocker (atenolol, 50 mg once/day), or with a predominantly beta 2-blocker (ICI 118551, 20 mg 3 times/day). Both drugs caused a decrease of heart rate, but the reduction by ICI 118551 was less pronounced at rest and no additional decline occurred at exercise. ICI 118551 did not affect blood pressure at rest, but during exercise diastolic blood pressure was higher than after a placebo. Atenolol lowered systolic blood pressure at rest and suppressed the exercise-induced increase in systolic blood pressure. At rest and during exercise plasma renin activity was lowered by predominantly beta 1-blockade and unchanged during beta 2-antagonism. The exercise-induced increase in plasma renin was, however, not affected by the beta 1-blocker. After atenolol the urinary excretion of aldosterone was decreased but the plasma aldosterone concentration was not changed. ICI 118551 did not alter plasma or urinary aldosterone. Our results therefore provide further evidence that the adrenoceptors mediating the release of renin at rest and during exercise in humans are partially of the beta 1-subtype, whereas beta 2-adrenergic receptors probably play only a minor role in the control of renin secretion, especially at exercise.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003020     DOI: 10.1152/jappl.1986.60.1.108

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects.

Authors:  T Mori; K Handa; Y Terao; H Tanaka; A Kiyonaga; M Shindo; A Matsunaga; J Sasaki; K Arakawa
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

Review 2.  Influence of antihypertensive drugs on exercise capacity.

Authors:  R Fagard; J Staessen; L Thijs; A Amery
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 3.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

4.  Cardiac beta 2-adrenoceptors and the inotropic response to exercise in man.

Authors:  C Nyarko-Adomfeh
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

5.  The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

Authors:  D Taverner; I G Mackay; K Craig; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

6.  Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise.

Authors:  E Bellissant; D Annane; C Thuillez; J F Giudicelli
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  β1-Adrenoreceptor Polymorphisms and Blood Pressure: 49S Variant Increases Plasma Renin But Not Blood Pressure in Hypertensive Patients.

Authors:  Alastair J Sandilands; Kevin M O'Shaughnessy
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.